AI assistant
AstraZeneca PLC — Remuneration Information 2015
Oct 1, 2015
5229_dirs_2015-10-01_84990082-afa5-4dad-aa25-cc01dc63a925.html
Remuneration Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 9167A
AstraZeneca PLC
01 October 2015
Transaction by Person Discharging Managerial Responsibilities
Disclosure Rule DTR 3.1.4
On 1 October 2015, the interest of Mr Pascal Soriot, a person discharging managerial responsibilities, in the ordinary shares of AstraZeneca PLC changed as detailed below.
The change in interest relates to the previously announced award of restricted shares made in October 2012 in connection with Mr Soriot's appointment as Chief Executive Officer. The award vests in three tranches over three years.
After sufficient shares were withheld to satisfy certain tax obligations arising on the vesting, Mr Soriot has become beneficially entitled to and has received 17,985 shares into a personal brokerage account in respect of the third and final tranche of the award.
For tax purposes, the fair market value of the shares at vest was 4181.5 pence per share being the closing price of AstraZeneca ordinary shares on the last trading day preceding the vesting day.
A C N Kemp
Company Secretary
1 October 2015
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSUAURRVOARRAA